Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
Top Cited Papers
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (3) , 1302-1313
- https://doi.org/10.1128/jvi.01272-09
Abstract
The membrane-proximal external region (MPER) of HIV-1, located at the C terminus of the gp41 ectodomain, is conserved and crucial for viral fusion. Three broadly neutralizing monoclonal antibodies (bnMAbs), 2F5, 4E10, and Z13e1, are directed against linear epitopes mapped to the MPER, making this conserved region an important potential vaccine target. However, no MPER antibodies have been definitively shown to provide protection against HIV challenge. Here, we show that both MAbs 2F5 and 4E10 can provide complete protection against mucosal simian-human immunodeficiency virus (SHIV) challenge in macaques. MAb 2F5 or 4E10 was administered intravenously at 50 mg/kg to groups of six male Indian rhesus macaques 1 day prior to and again 1 day following intrarectal challenge with SHIVBa-L. In both groups, five out of six animals showed complete protection and sterilizing immunity, while for one animal in each group a low level of viral replication following challenge could not be ruled out. The study confirms the protective potential of 2F5 and 4E10 and supports emphasis on HIV immunogen design based on the MPER region of gp41.Keywords
This publication has 53 references indexed in Scilit:
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine TargetScience, 2009
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challengeNature Medicine, 2009
- Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early InfectionJournal of Virology, 2007
- In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10Journal of Virology, 2007
- Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus ReplicationJournal of Virology, 2007
- Subdominant CD8+T-Cell Responses Are Involved in Durable Control of AIDS Virus ReplicationJournal of Virology, 2007
- Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector CellsJournal of Virology, 2006
- The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B
*
17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 ReplicationJournal of Virology, 2006
- Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)Antimicrobial Agents and Chemotherapy, 2006
- Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virionsProceedings of the National Academy of Sciences, 2003